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The development of allergic sensitization
and atopic disease in children is a function
of a genetic predisposition to react to anti-
gens and the timing and extent of exposure
to allergenic agents. Evidence is accumulat-
ing that indoor allergen exposure early in life
stimulates the development of allergic sensi-
tization (1–3). Because most children and
adults spend most of their time indoors,
much attention has been directed to identi-
fying indoor sources of allergens. House dust
is a complex mixture of various biocontami-
nants and a major source of allergens in non-
industrial indoor environments. House dust
contains allergens such as mites, epithels of
pet dander, and molds (1–6), and threshold
values at which exposure may cause sensitiza-
tion have been proposed. Although some
authors suggest sensitization to molds as a
risk factor for allergic diseases and asthma
(7,8), it is still unclear whether allergic sensi-
tization is a risk factor for asthma (9).
Epidemiologic studies reported positive asso-
ciations between respiratory symptoms and
living in damp houses (10–16), a condition
thought to permit mold growth. Yet little is
known about the contribution of indoor
mold levels to allergic sensitization rates
(17,18). Some reasons for the lack of infor-
mation are that environmental monitoring is
time and cost intensive and requires a high
level of subject cooperation. In the present
study we were able to use actual measure-
ment of mold spores instead of relying on
self-reports of mold growth to examine the
role viable mold spores contained in house
dust play in causing allergic sensitization and
asthmatic and allergic symptoms in children. 
Materials and Methods
Study population and selection of homes. We
conducted two cross-sectional surveys in
1992–1993 and 1995–1996 to study the
long-term health effects of ambient air pollu-
tion in German school children ages 5–14
years living in three areas of Saxony-Anhalt
[n = 2,470 children (89.1%) and n = 2,814
(74.7%) participation rate, respectively, for
each survey]. In both surveys, we elicited
information about social and environmental
factors (19) and asked parents to report aller-
gic and respiratory symptoms and diseases
for their children. In addition, our study
physician examined all children and drew
blood samples. For a select subgroup of chil-
dren we were able to collect additional data,
including samples of house dust and infor-
mation concerning building and housing
characteristics and living habits. 
Drawing from both survey populations,
we selected affected (case) and unaffected
(control) children; cases were deﬁned as chil-
dren who could be classified as atopic
according to at least one of the following
three criteria: a positive skin prick test; at
least one positive specific IgE test (CAP-
RAST-FEIA; IgE > 0.35 kU/L); or physician
diagnosis of asthma at any time before the
survey. We used a stratified random sam-
pling approach to select children in two age
groups (5–7 and 8–10 years) from three resi-
dential areas; 80 children each were selected
in the younger age group and between 40
and 50 in the older age group for a total of
370 case and 370 control children. Parents
of 231 selected case children (62%) agreed
to participate. Control children had to be
nonatopic and nonasthmatic (i.e., they did
not meet any of the above-mentioned criteria
for cases. Parents of 223 selected control chil-
dren (60%) agreed to participate. Overall,
parents of 454 children allowed us to collect
household dust samples. 
Trained personnel performed interviews
to document housing characteristics and vis-
ited homes twice at an interval of approxi-
mately 6 months to collect two dust samples.
All 454 homes were visited between 1996
and 1998, but for the following analyses we
considered only the homes of 340 children
(178 case and 162 control children) who did
not move between the medical examination
and the home visit. For the following sec-
ondary analyses focusing on mold exposure
and allergic sensitization, we excluded 20
subjects with missing data for IgE sensitiza-
tion and seven subjects missing other covari-
ate data. We further restricted our case group
to sensitized children only (i.e., those chil-
dren testing positive in at least one RAST
test), excluding 41 children who qualiﬁed as
Address correspondence to B. Jacob, GSF–Institute
of Epidemiology, Ingolstädter Landstr. 1 D-85758
Neuherberg, Germany. Telephone: +49-89-3187-
4150. Fax: +49-89-3187-3380. E-mail: beate.jacob@
t-online.de 
We thank G. Wölke and B. Hollstein for coordi-
nating the home visits. The Federal Ministry for
Education, Science, Research and Technology,
grant EE 93016, supported this study.
The Inga-Study Group: GSF—National Research
Center for Environment and Health, Neuherberg,
Institute of Epidemiology (H.E. Wichmann, J.
Heinrich, P. Schneider, J. Cyrys, I. Groß, G.
Wölke, G. Silbernagl, U. Gehring, B. Jacob, A.
Houzer), Institute of Ecological Chemistry (I.
Gebefügi, G. Lörinci, J. Schnelle); Friedrich Schiller
University—Jena Institute of Occupational, Social
and Environmental Medicine (W. Bischof, A.
Koch, J. Witthauer, K.J. Heilemann), Institute of
Clinical Immunology (L. Jäger, B. Fahlbusch, G.
Schlenvoigt); Großhansdorf Hospital—Hamburg
Center for Pneumology and Thoracic Surgery (H.
Magnussen, K. Richter, R. Jörres); University of
Utrecht—Division of Environmental and
Occupational Health (B. Brunekreef, J. Douwes,
G. Doekes).
Received 18 May 2001; accepted 17 December
2001.
Articles
Evidence that indoor dampness and mold growth are associated with respiratory health has been
accumulating, but few studies have been able to examine health risks in relation to measured lev-
els of indoor mold exposure. In particular, little is known about the contribution of indoor molds
to the development of allergic sensitization. As a part of an ongoing study examining the effects of
ambient air pollutants on respiratory health and atopic diseases in German school children, we
examined the relation between viable mold levels indoors and allergic sensitization in 272 chil-
dren. We examined whether allergic sensitization in children is associated with higher fungal
spore count in settled house dust sampled from living room ﬂoors. Adjusting for age, sex, parental
education, region of residency, and parental history of atopy, we found that mold spore counts
for Cladosporium and Aspergillus were associated with an increased risk of allergic sensitization.
Sensitized children exposed to high levels of mold spores (> 90th percentile) were more likely to
suffer from symptoms of rhinoconjunctivitis. We conclude that elevated indoor concentrations of
molds in wintertime might play a role in increasing the risk of developing atopic symptoms and
allergic sensitization not only to molds but also to other common, inhaled allergens. These effects
were strongest in the group of children who had lived in the same home since birth. Key words:
allergic sensitization, house dust, indoor allergen exposure, molds. Environ Health Perspect
110:647–653 (2002). [Online 24 May 2002]
http://ehpnet1.niehs.nih.gov/docs/2002/110p647-653jacob/abstract.htmlcases only according to a positive skin-prick
test. We considered the validity and reliabil-
ity of the prick test results questionable
because different test kits were used in each
survey. Thus, 115 cases and 157 controls
remained in the analyses. We chose to use
only house dust samples taken in winter
(November–April) to minimize the influ-
ence of seasonal variation (20) and to make
our results comparable to previous studies
using a similar restriction to winter sampling
(8,10,11,21–24).
Approval of the study protocol was
granted by the Ethics Committees of the
University of Rostock and the University of
Munich (LMU), and the study was per-
formed in accordance with the institutional
guidelines for the protection of human
subjects. Written informed consent was
obtained from the parents of all participating
children.
House dust sampling and mold identiﬁ-
cation. Dust sampling and extraction proce-
dures were identical to those used in a
parallel study of adults (25) and described in
more detail elsewhere (20,26). In each
home, a dust sample was taken from the liv-
ing room floor (97% were carpeted floors)
by vacuuming an area of 1 m2 for 2 min in a
highly standardized manner using the same
type of vacuum cleaner (Type Flüsterjet
Vitall 371, 1,000 W; Phillips, Hamburg,
Germany) and the same device (collector
and filter; ALK, Hørsholm, Denmark) to
collect dust on a paper ﬁlter (20). In general,
samples were obtained from carpets. The
dust filters were weighed before and after
vacuuming to analyze the settled dust gravi-
metrically. The dust samples were stored at
room temperature and analyses were per-
formed within 10 days after sampling.
We analyzed 30 mg (500 µm) sieved
house dust for identiﬁcation and quantiﬁca-
tion of viable molds. Dusts were diluted in
0.9% NaCl and plated on DG18 (dichloran-
18% glycerol agar) and 0.1 g/L chloram-
phenicol was added to prevent bacterial
growth. Plates were incubated at 25°C for
10 days (20,27), and all analyses were dupli-
cated. The number of colony-forming units
(CFU) was counted and expressed as CFU
per gram of dust. Colonies were identiﬁed to
genus level using high-powered microscopy
(Ergaval; Carl Zeiss, Jena, Germany). 
The total number of CFUs may be of
limited clinical and epidemiologic relevance
because spores from different species have
different allergenic potential (11). Therefore,
we studied both the total counts and the
counts of selected mold genera separately.
The detection limit for total molds was
1,000 CFU/g dust, and, in some cases (high
concentrations of total molds) for genus-
speciﬁc CFU, 10,000 CFU/g dust. 
Allergic sensitization. Blood collection,
centrifugation of blood, and serum storage
followed the protocol of the European
Community Respiratory Health Survey
(ECRHS) (19,28). The serum samples 
were stored at –20°C. Specific IgE for
Dermatophagoides pteronyssinus (d1), cat aller-
gens (e1), Cladosporium (m2), mixed grasses
(g6), and birch (t3) were measured by the
CAP-FEIA method by Pharmacia Diagnostics
(Freiburg, Germany) using identical batches
of reagents for all assays (29). The measure-
ment range was 0.35–100 kU/L, with a
detection limit < 0.35 kU/L. Allergic sensiti-
zation was defined as testing positive for at
least one speciﬁc IgE (≥ 0.35 kU/L).
Statistical analysis. We performed statis-
tical analyses using the statistical analysis
package SAS for Windows version 6.12 (SAS
Institute, Cary, NC, USA). We included in
our multivariate analyses only those children
for whom we had complete covariate data
for potential risk factors for atopic diseases
(age, sex, region of residency, educational
level of the parents, and positive parental
history of atopy) in addition to outcome and
exposure information. Thus, we performed a
complete-subject analysis for 272 children
(115 sensitized cases and 157 controls). 
Because of the log-normal distribution of
mold spore counts, we present the median
and the 25th and 90th percentile as mea-
sures of variation. We calculated the crude
prevalence for sensitized cases and controls
for binary response variables of allergic dis-
eases or symptoms. We used the nonpara-
metric Spearman rank-order coefficient (rs)
to determine the relationships between the
CFU of several genera of mold spores. 
Because established thresholds for mold
genera are lacking, we classiﬁed subjects into
three exposure categories (subjects exposed ≤
25th, 25th–90th, and > 90th percentile).
Multiple logistic regression analyses allowed
us to examine the effect of mold spore expo-
sures on allergic sensitization, atopic symp-
toms, and atopic diseases adjusting for a ﬁxed
set of potential confounding variables (age,
sex, region of residency, educational level of
the parents, and positive parental history of
atopy) by including them in the model. We
report adjusted odds ratios (OR) and 95%
confidence intervals (CI) for each allergic
outcome and mold exposure category.
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Table 1. Basic description of the study population of 272 children in eastern Germany.
Sensitized cases (n = 115) Controls (n = 157)
Characteristics No. Percent No. Percent
Demographic characteristic
Place of residency
Zerbst 42 36.5 49 31.2
Bitterfeld 20 17.4 32 20.4
Hettstedt 53 46.1 76 48.4
Sex 
Boys 71 61.7 79 50.3
Girls 44 38.3 78 49.7
Age
5–7 years 69 60.0 94 59.9
8–10 years 46 40.0 63 40.1
Parental education
≤ 10 grades 58 50.4 83 52.9
≥ 12 grades 57 49.6 74 47.1
Positive family history of atopy 29 25.2 27 17.2
Dampness at home 29 25.2 35 22.3
Living in the same apartment since birth 43 37.4 58 36.9
Allergic sensitization
≥ 1 RAST + 115 100 0
RAST Der p1 +4 8 41.7 0
RAST cat + 30 26.1 0
RAST birch + 39 33.9 0
RAST gras + 84 73.0 0
RAST Cladosporium +1 4 12.2 0
Allergic symptomsa
Sneezing attacks 16 13.9 4 2.6
Red eyes  19 16.5 5 3.2
Runny or stuffed nose 16 13.9 8 5.2
Red eyes and runny or stuffed nose  5 4.4 0 0.0
Persistent wheezing 8 7.5 3 2.0
Itching rash 33 29.2 14 9.1
Allergic diseases
Asthmab,c 17 14.8 0 0.0
Asthma attacksa 4 3.6 0 0.0
Hay feverb 12 10.4 1 0.7
Eczemab 23 20.0 14 9.0
aIn past 12 months. bLifetime diagnosis. cDoctor’s diagnosis of asthma, asthmoid bronchitis, or spastic bronchitis.Results
Study population. Table 1 presents charac-
teristics of the study group, including the
distribution of allergic sensitization (RAST-
CAP ≥ 1), allergic symptoms, and diseases of
sensitized cases and nonsensitized, nonasth-
matic controls. We observed allergic sensiti-
zation [defined as testing positive for one
speciﬁc IgE (> 0.35 kU/L) , i.e. for Der p1,
cat, birch, grass, or Cladosporium] for 115
children referred to as cases. Our study sam-
ple consists of 150 boys and 122 girls
because more boys tested positive for speciﬁc
IgE. Parents of children who were sensitized
and thus belonged to the case group self-
reported being atopic slightly more often
(25.2% vs. 17.2%) than parents of nonsensi-
tized children, but we observed no difference
in parental reports concerning dampness of
homes and residential mobility since birth of
the child in both groups.
Viable mold spore contamination of
homes. The average weight of house dust
taken from living room floors was 0.90 ±
0.85 g/m2 and was similar for case and con-
trol homes (0.87 ± 1.01 for cases; 0.92 ±
0.71 for controls), yet we observed a large
variation in mold levels between households.
Table 2 presents the distribution of number
of CFUs obtained per gram of dust taken in
winter for total (all species) mold spores and
selected groups of the most common molds
found in homes. Although CFU values var-
ied greatly, we found only one sample with
>1 0 6 CFU/g dust (76 × 106 CFU/g dust).
Furthermore, no sample was free of molds.
Restricting the period of analysis to winter
samples only (November–April) meant that
more than 60% of our samples were negative
for Alternaria spores, and spore frequency
was low in all samples positive for Alternaria
(geometric mean 26; 95% CI, 16–43; 90th
percentile, 10,000 CFU/g dust). Thus, we
present results only for three genera of mold
spores found most commonly in winter-
time—Cladosporium, Penicillium, and
Aspergillus. Figure 1 shows the cumulative
frequency of the mold concentrations in the
homes of cases and controls. 
Cladosporium and Penicillium species
were the most prevalent mold genera, but all
three molds were positively correlated with
and contributed to our total viable mold
spore counts in the wintertime (r = 0.52 for
Cladosporium, 0.49 for Penicillium, and 0.43
for Aspergillus) in both case and control
homes (Table 3).
Furthermore, Cladosporium levels were
not or were only weakly correlated with 
the indoor mold species Aspergillus and
Penicillium in both seasons, suggesting that
in the homes we studied two different pat-
terns of mold growth contributed to overall
high levels of mold spores; in the ﬁrst type of
home we found the typical indoor species
Aspergillus and Penicillium commonly grow-
ing on foodstuffs and houseplants (30), and
in the second type of home the dominant
species was Cladosporium, an outdoor fungus
that grows on textiles and foodstuffs when it
gains access to the indoor environment.
Allergic sensitization and mold spore
counts in household dust. We examined the
association between allergic sensitization of
children and mold spore counts in house-
hold dust in multiple logistic regression
models adjusting the odds ratios for sensiti-
zation (at least one RAST-CAP positive test)
Articles • Indoor exposure to molds and allergic sensitization
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Table 2. Distribution of CFU per gram dust for total and selected genera of mold spores on living room
ﬂoors of 272 households in eastern Germany.
Molds Sensitized cases (n = 115) Controls (n = 157)
Total molds
Geometric mean  81,367 71,118
95% CI 70,562–93 827 61,285–82,530
n < LOD (%) 0 (0%) 0 (0%)
25th Percentile 50,000 45,000
Median 85,000 75,000
90th Percentile 210,000 195,000
Cladosporium
Geometric mean  2,997 1,501
95% CI 1,531–5,867 804–2,804
n < LOD (%) 19 (16.5%) 35 (22.3%)
25th Percentile 5,000 5,000
Median 12,500 10,000
90th Percentile 40,000 30,000
Penicillium
Geometric mean 2,041 2,014
95% CI 942–4,425 1,049–3,866
n < LOD (%) 26 (22.6%) 35 (22.3%)
25th Percentile 5,000 5,000
Median 15,000 15,000
90th Percentile 55,000 50,000
Aspergillus
Geometric mean 856 245
95% CI 399–1,836) 117–513
n < LOD (%) 31 (27.0%) 65 (41.4%)
25th Percentile LOD LOD
Median 5,000 5,000
90th Percentile 30,000 25,000
LOD, Limit of detection. 
Figure 1. Cumulative frequency of the concentrations of molds in the homes of cases and controls.
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Total molds (CFU/g dust × 10–3 )
Controls
Cases
05 0 100 150 200 250 300 350 400
Cladosporium (CFU/g dust × 10–3 )
05 0 100 150 200 250 300 350 400
Aspergillus (CFU/g dust × 10–3 )
05 0 100 150 200 250 300 350 400
Penicillium (CFU/g dust × 10–3 )
05 0100 150 200 250 300 350 400by age, sex, residential region, parental edu-
cation, and parental history of atopy. 
High levels of Cladosporium (35,000
CFU/g dust or > 90th percentile) in winter-
time household dust approximately tripled
the risk of allergic sensitization in children
(OR ≥ 90th percentile, 2.93; 95% CI,
1.17–7.36). Aspergillus spores increased the
risk of allergic sensitization at a somewhat
lower level [i.e., when the spore count
increased above 25,000 CFU/g dust (25th
percentile; OR 25th–90th percentile, 2.11;
95% CI, 1.22–3.65; OR ≥ 90th percentile:
1.76; 95% CI, 0.73–4.28] (Table 4).
Sensitization of exposed children, however,
was not limited to Cladosporium (specific
IgE positive for Cladosporium). Rather, chil-
dren exposed to increased viable mold levels
were more likely to be sensitized to other
allergens as well, such as pollen, cat, or house
dust mites, similar to what has been reported
previously (17). Considering mite allergen
exposure as a potential confounder, we
included also Der p1 and Der f1 levels into
the model, but the results did not change
(data not shown).
For Penicillium and also for total molds
counts, we found slightly increased sensitiza-
tion risks with exposure at high levels of
mold spores in winter, but our effect esti-
mates were imprecise and included the null
value. In summer, however, Penicillium was
the most important indoor contributor to
overall sensitization (OR ≥ 90th percentile,
2.83; 95% CI, 1.25–6.44; data not shown).
Our results suggest a positive trend for
risk of general allergic sensitization—not just
to mold allergens—when children are
exposed to mold spores. When restricting the
analyses to children who lived in the same
apartment since birth (n = 101), odds ratios
increased for Aspergillus counts and showed a
dose–response pattern (OR 25th–90th per-
centile, 2.21; 95% CI, 0.83–5.90; OR ≥
90th percentile, 3.14; 95% CI, 0.63–15.7).
Effects were also observed for high levels of
Cladosporium (OR ≥ 90th percentile, 4.21;
95% CI, 0.72–24.7) and total molds counts
(OR ≥ 90th percentile, 2.53; 95% CI,
0.52–12.4), but because of the loss in study
subjects, the 95% confidence intervals
included the null value. We did not observe
consistent or strong associations with winter-
time Penicillium spore counts in house dust
(Figure 2).
Allergic symptoms and diseases and mold
spore counts in household dust. Sensitized
cases exposed to high levels of viable mold
spores (> 90th percentile) were more likely to
suffer from symptoms of rhinoconjunctivitis,
including pink eye and runny and/or con-
gested nose (OR 10.8 for total molds, OR
19. 8 for Cladosporium, and OR 23.8 for
Penicillium; Table 5). We did not have
enough subjects to draw a conclusion about
the occurrence of other atopic and allergic
symptoms and diseases, but in general high
mold spore counts of any type seemed to
increase symptom prevalence to some degree.
Discussion
Distribution of molds. Studies from
Germany (31), Sweden (9), Denmark, the
Netherlands (22), the United Kingdom (32),
and Michigan (USA) (24) reported that
Penicillium was the most prevalent indoor
mold genus, followed by Cladosporium,
whereas Aspergillus was the most commonly
isolated indoor mold in Israel (17). Although
the molds Cladosporium spp. and Alternaria
spp. are generally considered outdoor
species, they are also commonly found
indoors. Outdoor mold levels vary greatly
with season, and these variations may also
contribute to variations in indoor levels of
these molds. Therefore, we restricted our
analyses of indoor dust samples to those
taken in winter (November–April), when
Cladosporium and Alternaria are less likely to
grow outdoors. Aspergillus and Penicillium
are the two most frequently encountered
genera of indoor molds.The number of
CFUs per gram of settled house dust is gen-
erally higher than the number measured in
air samples because samples of settled dust
probably reflect a cumulative measure of
mold spores in homes. The number of
CFUs per gram of dust found in our study
was higher than those reported from other
studies that used surface sampling methods
(24). Our geometric mean of CFUs per gram
dust for total molds was 81,367 in the group
of sensitized cases and 71,118 in controls.
Verhoeff et al. (22) sampled settled dust from
Articles • Jacob et al.
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Table 3. Spearman correlation coefﬁcient matrix of the concentration of the mold spores on living room
ﬂoors in winter of 272 households of children in eastern Germany.
Controls
Cases Total molds Cladosporium Penicillium Aspergillus
Total Molds
r 1.0 0.47 0.49 0.37
p-Value 0.0001 0.0001 0.0001
Cladosporium
r 0.55 1.0 –0.003 0.11
p-Value 0.0001 0.975 0.254
Penicillium
r 0.48 0.09 1.0 0.27
p-Value 0.0001 0.240 0.003
Aspergillus
r 0.44 0.19 0.25 1.0
p-Value 0.0001 0.019 0.002
Figure 2. Percentage of sensitized children in the quartiles of exposure to molds (cases and controls).
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smostly noncarpeted bedroom floors over 2
months (October–November) and reported
8,300 CFU/g dust in homes of children with
respiratory symptoms and 9,940 CFU/g dust
in control household samples. Wickmann (9)
reported a mean of only 1,000 CFU/g dust
sampled from living room ﬂoors in late winter
(February–March). Total numbers of CFUs
per gram dust from carpets are signiﬁcantly
higher than for smooth ﬂoors (22), and 97%
of our samples were taken from carpeted
ﬂoors, which may explain the differences.
However, comparisons of quantitative
and qualitative results from different studies
are of limited value because studies not only
used different sampling techniques for the
same mold spores, but each study also
focused on the identiﬁcation of unique and
different sets of mold spores (33,34). 
Molds and allergic sensitization.
Sensitization to molds is a risk factor for
allergic diseases (8,9), and molds can be
important indoor allergens (17). Reports of
prevalence of allergic sensitization to molds
vary widely ranging from 2% to 30% in
subjects with respiratory allergy (35). The
great variability in reported prevalence could
derive from differences in environmental
conditions, such as the geoclimatic areas
under investigation, differences in population
sensitivity, and differences in the characteris-
tics and properties of diagnostic tests used to
assess allergen extracts (33). The number of
mold allergens for which reliable tests are
available is small compared to other allergen
extracts such as mites. Furthermore, isola-
tion, purification, and standardization of
allergens produced by molds are a major
problem contributing to measurement error
of unknown size in all studies.
The likelihood of developing sensitivity
to aeroallergens depends on the degree of
atopic susceptibility, the concentration and
potency of allergens one is exposed to, and
adjuvant factors (36). As did Garrett et al.
(37), we found that winter exposure to high
concentrations of mold spores such as
Cladosporium increased allergic sensitiza-
tion. Garrett et al. (37) also reported that
atopy was significantly associated with
Aspergillus. In our study, effects were most
consistently observed for the species of
Cladosporium and Aspergillus, where expo-
sure above the 90th percentile increased the
risk of allergic sensitization approximately
2- or 3-fold (Cladosporium, OR, 2.93; 95%
CI, 1.17–7.36; Aspergillus, OR, 2.11; 95%
CI, 1.22–3.65). Exposure to high levels of
Penicillium (> 55,000 CFU/g dust, > 90th
percentile) elevated the risk for allergic
sensitization in winter only slightly, but
Penicillium was the dominant indoor mold
allergen in summer.
Although we conducted analyses stratify-
ing for season (summer and winter), these
analyses were not always informative because
the sample was small. Summer total mold
counts were dominated by high counts for
the outdoor molds Cladosporium and
Alternaria, and counts for these species corre-
lated only weakly with the counts for the
indoor molds Pencillium and Aspergillus (data
not shown). We also observed that indoor
Cladosporium measures were much higher in
summer than in winter (median of 35,000
CFU/g in summer vs. 10,000 CFU/g in
winter), while an opposite but weaker sea-
sonal pattern was found for Aspergillus and
Penicillium, supporting our notion that at
least two different patterns of mold contami-
nation of homes exist in the geographic area
we studied. The latter two molds were more
abundant in our winter samples.
Our winter results did not change when
we adjusted for summertime spore counts
from the same households or when we
adjusted for house dust mite allergens
(results not shown), and our results were
strengthened when we restricted the analyses
to children living in the same home since
birth, but sample size and statistical effi-
ciency was limited for this and other types of
subgroup analyses (e.g., multiple logistic
regression models examining sensistization
to specific instead of all allergens; data not
shown). As in our study, Garrett et al. (37)
reported an elevated risk of general sensitiza-
tion to allergens such as dust mites and dog
allergens when they found high levels of
viable Cladosporium and Penicillium spores
in the air of homes in wintertime. Also simi-
lar to our results, these associations weak-
ened when Garrett and co-workers instead
used spore samples collected in late spring
(37). This may be related to the known sea-
sonal variability of mold spores in outdoor
air (i.e., in winter levels of viable mold spore
contamination in homes depend mostly on
indoor factors because it is unlikely that
spores are carried in from outdoors). 
Molds and allergic symptoms. High
indoor mold exposure (> 90th percentile)
seems to contribute to allergic symptoms
and diseases in both sensitized and nonsensi-
tized children; however, because numbers in
the nonsensitized group were small, effect
estimates were imprecise or even nones-
timable in this subgroup. This might suggest
that both inﬂammatory allergic mechanisms,
including type III allergy to mold-specific
antigens and nonimmune inflammatory
reactions to mold components, might be
important (18). It is not clear which inﬂam-
matory and/or allergic mechanisms primarily
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Table 5. Adjusted odds ratios for atopic symptoms and diseases and indoor mold spore counts.
OR for fungal exposure above the 90th percentilea
Atopic symptoms Total molds Cladosporium Penicillium Aspergillus
Sneezing attacksb 3.47 (1.07–11.3) 1.43 (0.36–5.58) 2.12 (0.52–8.63) NE
Red eyes and runny  11.3 (1.23–103.1) 15.5 (2.08–1154.0) 17.6 (1.69–183.4) NE
or congested noseb
Persistent wheezingb 0.82 (0.10–7.13) 1.18 (0.47–2.94) 2.55 (0.44–14.7) 2.15 (0.41–11.4)
Itching rashb 1.46 (0.54–3.96) 1.18 (0.41–3.39) 0.62 (0.17–2.24) 1.47 (0.55–3.93)
Asthmac,d 0.47 (0.06–3.90) 0.52 (0.06–4.27) 1.74 (0.35–8.73) 1.29 (0.27–6.18)
Hay feverc 2.14 (0.39–11.8) 1.89 (0.35 –10.3) 2.57 (0.54–12.3) NE
Eczemac 1.65 (0.57–4.81) 0.54 (0.12–2.44) 1.21 (0.38–3.88) 2.16 (0.80–2.52)
NE, not estimable.
aAdjusted for age, sex, region of residency, parental education, and parental atopy. bIn past 12 months. cLifetime.
dAsthma, asthmoid bronchitis, or spastic bronchitis. 
Table 4. Associations between exposure to fungal spores and prevalence of allergic sensitization.
Sensitized Crude OR Adjusted ORa
Molds (CFU/g dust) cases Controls (95% CI) (95% CI)
Total molds
≤ 25th Percentile ≤ 48.750 24 44 1.0 1.0
> 25th/≤ 90th Percentile 48.750–200.000 79 100 1.45 (0.81–2.58) 1.56 (0.85–2.86)
> 90th Percentile > 200.000 12 13 1.69 (0.67–4.29) 1.67 (0.65–4.29)
Cladosporium
≤ 25th Percentile ≤ 5.000 45 72 1.0 1.0
> 25th/≤ 90th Percentile 5.000–35.000 54 76 1.14 (0.68–1.89) 1.15 (0.67–1.95)
> 90th Percentile > 35.000 16 9 2.84 (1.16–6.98) 2.93 (1.17–7.36)
Penicillium
≤ 25th Percentile ≤ 5.000 40 60 1.0 1.0
> 25th/≤ 90th Percentile 5.000–55.000 64 85 1.13 (0.68–1.89) 1.09 (0.64–1.84)
> 90th Percentile > 55.000 11 12 1.38 (0.55–3.42) 1.38 (0.54–3.51)
Aspergillus
≤ 25th Percentile LOD 31 65 1.0 1.0
> 25th/≤ 90th Percentile LOD–25.000 72 77 2.06 (1.16–3.35) 2.11 (1.22–3.65)
> 90th Percentile > 25.000 12 15 1.68 (0.70–4.01) 1.76 (0.73–4.28)
LOD, limit of detection.
aAdjusted for age, sex, residential region, parental education, and parental atopy.account for the presumed pathogenic effects
of mold exposure (18). Nevertheless, allergic
sensitization to mold spores plays a major
role in atopy (14).
Existing studies suggest that exposure to
allergens during a sensitive period in early
life may enhance the risk of sensitization in
genetically predisposed children (35), imply-
ing that for children with a positive family
history, lower allergen concentrations may
be sufﬁcient to achieve sensitization (1). We
did not observe clear patterns for increased
sensitization risk in children with a positive
history of parental atopy (data not shown),
but the number of children in this group was
quite small (n = 56), and we sampled mold
spores in homes only for children older than
5 years of age.
Sampling technique and identification
methods. The presence of molds in indoor
environments is generally assessed using air
or surface samples (13). Air sampling of
viable mold particles usually is restricted to
short periods of several hours and does not
provide reliable data concerning the contam-
ination by and growth of molds in nonin-
dustrial indoor environments (34), especially
because airborne samples are strongly inﬂu-
enced by outdoor levels of molds. High sam-
pling variation has been observed for total
airborne spore burden in repeated samples
taken in the same home, possibly caused by
domestic activity, cleaning, and ventilation
(22). Assessment of viable mold particles
(mold propagules) in settled house dust
might be a useful measure of longer-term
and cumulative exposure to indoor molds
and is less inﬂuenced by indoor activities and
turbulence. We used a simple, settled-dust
sampling technique of standardized vacuum-
ing of ﬂoor dust in the living room to mea-
sure viable mold particles. 
To date, analysis of housedust samples to
identify viable mold particles has not been
standardized. Recently, a comparative study
of 10 different analytic methods, however,
showed that direct plating of dust onto DG18
agar was one of the more sensitive methods
(27). In fact, use of DG18 agar produced
higher numbers of CFU for all mold spores.
As an alternative to sampling mold
spores, participants in previous studies of
allergic and asthmatic diseases have often
been asked to report dampness and odors as
a surrogate for indoor mold exposures (14).
Awareness of the existence of such exposures,
however, may have caused overreporting of
symptoms in exposed subjects and thus may
have led to response bias. Furthermore, air
sampling and cultivation of spores from
house dust samples show only a modest
agreement with such self-reported exposures
(11,37). In the present study, relying on dust
samples avoided reporting biases. But
confounding bias may have occurred due to
the fact that we included sensitized asthmat-
ics in our case goup, and homes of asthmatics
may be cleaned more rigorously to avoid
symptoms. When we excluded from our
analyses 17 children who were both asthmat-
ics and sensitized, our results did not change.
We standardized our method of house
dust sampling. We also believe that settled
dust may be the best proxy for long-term
exposures to mold allergens in the home
environment. Furthermore, approximately
30% of all children for whom we collected
samples had lived in the same home since
birth and may have been exposed to high lev-
els of mold throughout their lives.To explore
fully any exposure–response relation between
allergic sensitization and exposure to indoor
molds, it is necessary to recruit sufficient
individuals with high and low exposure lev-
els. Although we found a wide range of
CFUs per gram of dust in the homes of our
study subjects, our overall sample size was
relatively small and further reduced when we
restricted our analyses to dust samples taken
during wintertime to minimize the effect of
seasonal variability in molds.
Conclusions
Our results suggest that indoor mold spore
exposure, mainly during winter, might
increase the risk of sensitization to all aller-
gens in children. These ﬁndings are limited
by methodologic difficulties of quantifying
molds and by the relatively small number of
homes studied. For future research we
encourage using a longitudinal study design
with a larger number of cases to allow analy-
ses for allergen-speciﬁc instead of total sensi-
tization. However, we found that allergic
sensitization was signiﬁcantly associated with
exposure to one or more genera of indoor
mold spores, even after adjustment for house
dust mite exposure. The effect strengthened
when we restricted our study population to
children who had lived in the same home
since birth. Furthermore, our study suggests
that high indoor spore counts might increase
the prevalence of allergic symptoms in all
children whether they are sensitized or not. 
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